PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.79%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
987.72%
Gross profit growth above 1.5x ANO.AX's 251.94%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
165.89%
EBIT growth similar to ANO.AX's 155.25%. Walter Schloss might infer both firms share similar operational efficiencies.
165.89%
Operating income growth under 50% of ANO.AX's 648.74%. Michael Burry would be concerned about deeper cost or sales issues.
479.74%
Net income growth above 1.5x ANO.AX's 161.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
Share reduction while ANO.AX is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.46%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-163.38%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-201.42%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
10.79%
10Y revenue/share CAGR under 50% of ANO.AX's 223.10%. Michael Burry would suspect a lasting competitive disadvantage.
119.97%
Positive 5Y CAGR while ANO.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-28.44%
Negative 3Y CAGR while ANO.AX stands at 6.96%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1016.95%
Negative 10Y OCF/share CAGR while ANO.AX stands at 77.99%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-462.70%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-47.31%
Negative 3Y OCF/share CAGR while ANO.AX stands at 878.66%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
336.32%
Below 50% of ANO.AX's 4293.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1037.50%
Positive 5Y CAGR while ANO.AX is negative. John Neff might view this as a strong mid-term relative advantage.
-62.50%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
99.31%
5Y equity/share CAGR above 1.5x ANO.AX's 53.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
55.73%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.72%
AR growth is negative/stable vs. ANO.AX's 53.52%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
30.13%
We show growth while ANO.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.81%
Negative asset growth while ANO.AX invests at 3.20%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
8.82%
BV/share growth above 1.5x ANO.AX's 2.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-10.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
133.02%
SG&A growth well above ANO.AX's 14.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.